ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 357 out of 2094

$630K Total Retail Price of All Prescriptions

Rank: 319 out of 2094

193 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 193 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 7,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

55% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
NEXIUM 315 315 1 16
ZOLPIDEM TARTRATE 298 298 2 14
CRESTOR 268 264 3 15
DIOVAN 251 251 4 13
AMLODIPINE BESYLATE 248 244 5 2
ATENOLOL 226 226 6 21
SIMVASTATIN 215 207 7 1
LOVAZA 203 203 8 53
DONEPEZIL HCL 170 170 9 20
LEVOXYL 160 160 10 130
ATORVASTATIN CALCIUM 157 151 11 5
METFORMIN HCL 156 152 12 8
LEXAPRO 137 137 13 180
SERTRALINE HCL 132 132 14 26
METOPROLOL SUCCINATE 125 125 15 9
DEXILANT 124 124 16 124
LIPITOR 111 108 17 39
MELOXICAM 111 110 17 49
MICARDIS 109 109 19 252
HYDROCHLOROTHIAZIDE 105 102 20 12
ESCITALOPRAM OXALATE 100 100 21 46
LIDODERM 92 92 22 59
METOPROLOL TARTRATE 91 91 23 10
WARFARIN SODIUM 87 87 24 11
MECLIZINE HCL 86 86 25 103
CLONIDINE HCL 75 75 26 62
TAMSULOSIN HCL 75 75 26 29
DIOVAN HCT 74 74 28 28
OMEPRAZOLE 71 71 29 4
JANUVIA 70 70 30 35
CLOPIDOGREL 68 65 31 22
SYNTHROID 68 68 31 44
PLAVIX 68 68 31 38
LOSARTAN POTASSIUM 68 58 31 17
LEVOTHYROXINE SODIUM 67 59 35 3
BENICAR 66 66 36 108
ZALEPLON 66 66 36 466
CREON 65 65 38 219
SPIRONOLACTONE 64 63 39 93
ADVAIR DISKUS 62 61 40 36
ALENDRONATE SODIUM 57 57 41 30
AZITHROMYCIN 57 54 41 27
GLIPIZIDE XL 56 56 43 122
TRAMADOL HCL 54 54 44 33
LISINOPRIL 53 51 45 7
ONGLYZA 52 52 46 134
FUROSEMIDE 51 51 47 6
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.